Report Detail
Global (United States, European Union and China) Colorectal Cancer Therapeutics Market Research Report 2019-2025
- RnM3689333 |
- 22 August, 2019 |
- Global |
- 120 Pages |
- QYResearch |
- Pharma & Healthcare
Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time
In 2019, the market size of Colorectal Cancer Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Colorectal Cancer Therapeutics.
This report studies the global market size of Colorectal Cancer Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Colorectal Cancer Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Taiho Pharma
Merck KGaA
Amgen
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx
Bristol-Myers Squib
Sumitomo Dainippon Pharma
Array BioPharma
Hutchison MediPharma
Jiangsu Hengrui Medicine
Jiangsu Chia-Tai Tianqing
Suzhou Zelgen Biopharmaceuticals
Market Segment by Product Type
Diagnostics
Therapeutics
Market Segment by Application
Hospitals
Clinic
Research institutions
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Colorectal Cancer Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Colorectal Cancer Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Colorectal Cancer Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Colorectal Cancer Therapeutics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Diagnostics
- 1.3.3 Therapeutics
- 1.4 Market Segment by Application
- 1.4.1 Global Colorectal Cancer Therapeutics Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Clinic
- 1.4.4 Research institutions
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Colorectal Cancer Therapeutics Market Size
- 2.1.1 Global Colorectal Cancer Therapeutics Revenue 2014-2025
- 2.1.2 Global Colorectal Cancer Therapeutics Sales 2014-2025
- 2.2 Colorectal Cancer Therapeutics Growth Rate by Regions
- 2.2.1 Global Colorectal Cancer Therapeutics Sales by Regions 2014-2019
- 2.2.2 Global Colorectal Cancer Therapeutics Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Colorectal Cancer Therapeutics Sales by Manufacturers
- 3.1.1 Colorectal Cancer Therapeutics Sales by Manufacturers 2014-2019
- 3.1.2 Colorectal Cancer Therapeutics Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Colorectal Cancer Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Colorectal Cancer Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Colorectal Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.3 Colorectal Cancer Therapeutics Price by Manufacturers
- 3.4 Key Manufacturers Colorectal Cancer Therapeutics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Colorectal Cancer Therapeutics Market
- 3.6 Key Manufacturers Colorectal Cancer Therapeutics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Diagnostics Sales and Revenue (2014-2019)
- 4.1.2 Therapeutics Sales and Revenue (2014-2019)
- 4.2 Global Colorectal Cancer Therapeutics Sales Market Share by Type
- 4.3 Global Colorectal Cancer Therapeutics Revenue Market Share by Type
- 4.4 Colorectal Cancer Therapeutics Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Colorectal Cancer Therapeutics Sales by Application
6 United States
- 6.1 United States Colorectal Cancer Therapeutics Breakdown Data by Company
- 6.2 United States Colorectal Cancer Therapeutics Breakdown Data by Type
- 6.3 United States Colorectal Cancer Therapeutics Breakdown Data by Application
7 European Union
- 7.1 European Union Colorectal Cancer Therapeutics Breakdown Data by Company
- 7.2 European Union Colorectal Cancer Therapeutics Breakdown Data by Type
- 7.3 European Union Colorectal Cancer Therapeutics Breakdown Data by Application
8 China
- 8.1 China Colorectal Cancer Therapeutics Breakdown Data by Company
- 8.2 China Colorectal Cancer Therapeutics Breakdown Data by Type
- 8.3 China Colorectal Cancer Therapeutics Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Colorectal Cancer Therapeutics Breakdown Data by Company
- 9.2 Rest of World Colorectal Cancer Therapeutics Breakdown Data by Type
- 9.3 Rest of World Colorectal Cancer Therapeutics Breakdown Data by Application
- 9.4 Rest of World Colorectal Cancer Therapeutics Breakdown Data by Countries
- 9.4.1 Rest of World Colorectal Cancer Therapeutics Sales by Countries
- 9.4.2 Rest of World Colorectal Cancer Therapeutics Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Taiho Pharma
- 10.1.1 Taiho Pharma Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Colorectal Cancer Therapeutics
- 10.1.4 Colorectal Cancer Therapeutics Product Introduction
- 10.1.5 Taiho Pharma Recent Development
- 10.2 Merck KGaA
- 10.2.1 Merck KGaA Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Colorectal Cancer Therapeutics
- 10.2.4 Colorectal Cancer Therapeutics Product Introduction
- 10.2.5 Merck KGaA Recent Development
- 10.3 Amgen
- 10.3.1 Amgen Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Colorectal Cancer Therapeutics
- 10.3.4 Colorectal Cancer Therapeutics Product Introduction
- 10.3.5 Amgen Recent Development
- 10.4 Takeda
- 10.4.1 Takeda Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Colorectal Cancer Therapeutics
- 10.4.4 Colorectal Cancer Therapeutics Product Introduction
- 10.4.5 Takeda Recent Development
- 10.5 Roche
- 10.5.1 Roche Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Colorectal Cancer Therapeutics
- 10.5.4 Colorectal Cancer Therapeutics Product Introduction
- 10.5.5 Roche Recent Development
- 10.6 Eli Lilly
- 10.6.1 Eli Lilly Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Colorectal Cancer Therapeutics
- 10.6.4 Colorectal Cancer Therapeutics Product Introduction
- 10.6.5 Eli Lilly Recent Development
- 10.7 Sanofi
- 10.7.1 Sanofi Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Colorectal Cancer Therapeutics
- 10.7.4 Colorectal Cancer Therapeutics Product Introduction
- 10.7.5 Sanofi Recent Development
- 10.8 Regeneron
- 10.8.1 Regeneron Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Colorectal Cancer Therapeutics
- 10.8.4 Colorectal Cancer Therapeutics Product Introduction
- 10.8.5 Regeneron Recent Development
- 10.9 Bayer
- 10.9.1 Bayer Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Colorectal Cancer Therapeutics
- 10.9.4 Colorectal Cancer Therapeutics Product Introduction
- 10.9.5 Bayer Recent Development
- 10.10 Onyx
- 10.10.1 Onyx Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Colorectal Cancer Therapeutics
- 10.10.4 Colorectal Cancer Therapeutics Product Introduction
- 10.10.5 Onyx Recent Development
- 10.11 Bristol-Myers Squib
- 10.12 Sumitomo Dainippon Pharma
- 10.13 Array BioPharma
- 10.14 Hutchison MediPharma
- 10.15 Jiangsu Hengrui Medicine
- 10.16 Jiangsu Chia-Tai Tianqing
- 10.17 Suzhou Zelgen Biopharmaceuticals
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Colorectal Cancer Therapeutics Sales Channels
- 11.2.2 Colorectal Cancer Therapeutics Distributors
- 11.3 Colorectal Cancer Therapeutics Customers
12 Market Forecast
- 12.1 Global Colorectal Cancer Therapeutics Sales and Revenue Forecast 2019-2025
- 12.2 Global Colorectal Cancer Therapeutics Sales Forecast by Type
- 12.3 Global Colorectal Cancer Therapeutics Sales Forecast by Application
- 12.4 Colorectal Cancer Therapeutics Forecast by Regions
- 12.4.1 Global Colorectal Cancer Therapeutics Sales Forecast by Regions 2019-2025
- 12.4.2 Global Colorectal Cancer Therapeutics Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Colorectal Cancer Therapeutics. Industry analysis & Market Report on Colorectal Cancer Therapeutics is a syndicated market report, published as Global (United States, European Union and China) Colorectal Cancer Therapeutics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Colorectal Cancer Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
